trending Market Intelligence /marketintelligence/en/news-insights/trending/lhi5so0rq686ff3ntfiora2 content esgSubNav
In This List

Tonix Pharmaceuticals names board member

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Tonix Pharmaceuticals names board member

New York-based Tonix Pharmaceuticals Holding Corp. appointed Adeoye Olukotun to its board.

He succeeds Ernest Mario, who stepped down as a director.

Olukotun is CEO of CR Strategies LLC, a clinical research and development consulting firm. His previous roles include CEO of EpiGen Pharmaceuticals Inc. and former vice chairman and CEO of CardioVax Inc.

Tonix Pharmaceuticals has two therapeutic programs focused on post-traumatic stress disorder.